Gamida Cell Ltd. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Net loss
Depreciation of property, equipment and right-of-use assets
Financial loss (income), net
Share-based compensation
Change in employee benefit liabilities, net
Amortization of premium on marketable securities
Revaluation of liabilities presented at fair value
Revaluation of liability to IIA
Adjustments to reconcile profit (loss)
Increase (decrease) in other receivables, prepaid expenses and other assets
Increase (decrease) in trade payables
Increase in accrued expenses and other payables
Cash flows from (used in) operations
Interest received
Interest paid
Net cash used in operating activities
Purchase of property, plant and equipment
Purchase of marketable securities
Investment in restricted bank deposits
Proceeds from maturity of marketable securities
Net cash provided by (used in) investing activities
Proceeds from secondary offering, net
Proceeds from secondary offerings, net
Receipt of grants from the IIA
Proceeds from issuance of shares, initial public offering (payment of issuance expenses), net
Payment of lease liabilities
Proceeds from exercise of options
Net cash provided by financing activities
Exchange differences on balances of cash and cash equivalents
Increase in cash and cash equivalents
Cash flows from operating activities:
Net Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment
Financing expense (income), net
Share-based compensation
Change in fair value of warrants liability
Change in fair value in convertible note
Warrants liability issuance costs
Amortization of debt discount and issuance costs
Loss from sale of equipment
Change in assets and liabilities:
Increase in inventory
Operating lease right-of-use assets
Operating lease liabilities
Decrease (increase) accrued severance pay, net
Increase in accounts receivable
Decrease in prepaid expenses and other assets
Decrease in trade payables
Decrease (increase) in accrued expenses and current liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property, plant and equipment
Purchase of marketable securities
Proceeds from maturity of marketable securities
Investment in restricted deposits
Proceeds from restricted deposits
Proceeds from sale of equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from exercise of warrants liability
Proceeds from exercise of options
Proceeds from share issuance, net
Principal payments of convertible senior note
Proceeds from share issuance and warrants liability, net
Proceeds from issuance of convertible senior notes, net
Net cash provided by financing activities
Increase (decrease) in cash and cash equivalents
Effect of exchange rate changed on cash and cash equivalents
Decrease (increase) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Significant non-cash transactions:
IIA liability for grants to be received
Exercise of warrants liabilities to equity
Issuance expenses on credit
Lease liabilities arising from new right-of-use asset
Purchase of property, plant and equipment on credit
Conversion of convertible senior note
Reclassification from property, plant and equipment to inventory
Cash paid for interest

Comments